SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVAS-an interesting california-based biotech company here
CVAS 0.0004000.0%Oct 7 9:32 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (86)5/17/2002 11:39:54 AM
From: keokalani'nui  Read Replies (2) of 126
 
additional efficacy model for lead proteosome inhibitor

I thought lead cancer target was a membrane-bound protease. In any event, cancer program is embryonic.

PK before P2b in ACS? I listened to last CC and CIBC, and PK trial was not mentioned AT ALL. That is a shock, and tells me this company is now very afraid.

Was close to bottom fishing, now not so sure.

Wilder
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext